Drug intelligence / Profile preview

Cuitang granules

Development stage: Unknown
Lead developer: Beijing Hospital of Traditional Chinese Medicine
Modality: Small Molecules
Administration: Oral

Overview

Cuitang granules is a Traditional Chinese Medicine (TCM) formulation developed by the Beijing Hospital of Traditional Chinese Medicine, which is affiliated with Capital Medical University. It is specifically designed for the treatment of the common cold. As a TCM preparation, it typically consists of a complex mixture of herbal extracts intended to relieve symptoms associated with upper respiratory tract infections, such as fever, cough, and congestion. The drug has been evaluated in Phase III clinical trials to establish its efficacy and safety profile in patients suffering from the common cold.

Brand names: Cuitang granules
Other names: Cui-Tang Granules

Beyond the preview

Go deeper on Cuitang granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cuitang granules.

Explore the full profile